Product Information
GS DUAL ACTION PAIN 250-125 MG is a generic product labeled by L. Perrigo Company, priced at $0.1058 per EA under NDC 00113530068. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Feb 28, 2023.
Strength
250; 125 mg/1; mg/1
Manufacturer
L. Perrigo CompanyNDC
00113530068
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA214836FDA Approved
2/28/2023
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for GS DUAL ACTION PAIN 250-125 MG has been published 127 times since Mar 20, 2024, and over the history we have for it it has risen 67.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.1058 |
| 52-week low | $0.0839 |
| Median price | $0.0894 |
| Average price | $0.0863 |
| Largest weekly change | +15.2% (Jul 17, 2024) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GS DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for GS DUAL ACTION PAIN 250-125 MG, manufactured by L. Perrigo Company, is $0.1058 per EA (NDC 00113530068), effective Aug 19, 2026.
How has the price of GS DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for GS DUAL ACTION PAIN 250-125 MG has risen 67.8%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for GS DUAL ACTION PAIN 250-125 MG?
Since Mar 20, 2024, the NADAC for GS DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0894 per EA.
Are there cheaper alternatives to GS DUAL ACTION PAIN 250-125 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS DUAL ACTION PAIN 250-125 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GS DUAL ACTION PAIN 250-125 MG?
GS DUAL ACTION PAIN 250-125 MG (NDC 00113530068) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.